Urea levels and cardiovascular disease in patients with chronic kidney disease
Solène M. Laville(Centre Hospitalier Universitaire Amiens-Picardie), Mohamed Jamali, Denis Fouque(Université Claude Bernard Lyon 1), Bruno Moulin(Université de Strasbourg), Éric Magnant, Thierry Lobbedez, Thierry Hannedouche, Karine Legrand(Centre Hospitalier Universitaire Amiens-Picardie), Bruce Robinson(University of Michigan), Marie Metzger, Sébastien Mailliez, Carole Ayav(Inserm), Sophie Liabeuf(Centre Hospitalier Universitaire Amiens-Picardie), Christian Jacquelinet(Université Paris-Sud), Dorothée Cannet, Gaëtan Lebrun(Assistance Publique – Hôpitaux de Paris), Oriane Lambert(Inserm), Gabriel Choukroun(Centre Hospitalier Universitaire Amiens-Picardie), Hacène Sekhri, Benjamin Deroure, Bénédicte Stengel(Inserm), Ziad A. Massy(Inserm), Élodie Speyer, Nicolas Mansencal(Hôpital Ambroise-Paré), A. Couturier(Assistance Publique – Hôpitaux de Paris), Adeline Lacraz(Centre Hospitalier Universitaire de Bordeaux), Marie Essig, Christophe Pascal, Raymond Azar, Serge Briançon, Céline Lange, G Lambrey, Jean Philippe(Aix-Marseille Université), Yves-Édouard Herpe, Mustafa Smati, Christian Combe(Université de Bordeaux)
Cited by 69
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766